CELECOXIB
- Product NDC
- 50090-6380
- 11-digit product format
- 500906380
- Labeler code
- 50090
- Product ID
- 50090-6380_9817a8a2-182e-49dc-8c56-e21656eae510
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA204776
- Marketing category
- ANDA
- Marketing start
- 2018-06-01
- Substance
- CELECOXIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CELECOXIB
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CELECOXIB | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JCX84Q7J1L |
| Rxcui | 205322 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6380-0 | CELECOXIB | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
| 50090-6380-1 | CELECOXIB | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6380 | CELECOXIB (CELECOXIB) CAPSULE [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 2 package rows | 20230302_c7a183dc-f4d5-483f-964c-f2745a3640ad.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6380-0 | 50090638000 | 30 CAPSULE in 1 BOTTLE (50090-6380-0) | 30 capsule | 2023-02-23 | No | No | Current |
| 50090-6380-1 | 50090638001 | 90 CAPSULE in 1 BOTTLE (50090-6380-1) | 90 capsule | 2023-02-23 | No | No | Current |